Case Number 9980
Request Date 02/02/2024
Completion Date 22/02/2023

 

Details of the Request

Q1. How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:

  • Adalimumab - Humira
  • Adalimumab Biosimilar
  • Etrasimod
  • Filgotinib
  • Golimumab
  • Infliximab - Remicade
  • Infliximab Biosimilar
  • Mirikizumab
  • Ozanimod
  • Risankizumab
  • Tofacitinib
  • Upadacitinib
  • Ustekinumab
  • Vedolizumab

 

Q2 If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Ulcerative Colitis ONLY with the following biologic drugs:

  • Adalimumab - Humira
  • Adalimumab Biosimilar
  • Etrasimod
  • Filgotinib
  • Golimumab
  • Infliximab - Remicade
  • Infliximab Biosimilar
  • Mirikizumab
  • Ozanimod
  • Risankizumab
  • Tofacitinib
  • Upadacitinib
  • Ustekinumab
  • Vedolizumab

 

Details of the Response

Q1. How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:

  • Adalimumab - Humira = 58
  • Adalimumab Biosimilar = 369
  • Etrasimod = 0
  • Filgotinib = 5
  • Golimumab = 7
  • Infliximab - Remicade = 1
  • Infliximab Biosimilar = 138
  • Mirikizumab = 0
  • Ozanimod = 0
  • Risankizumab = 21
  • Tofacitinib = 13
  • Upadacitinib = 22
  • Ustekinumab = 111
  • Vedolizumab = 80

 

Q2 If you are able to link patient treatment to a disease, could you please provide the number of patients treated in the last 3 months for Ulcerative Colitis ONLY with the following biologic drugs:

  • Adalimumab - Humira = 2
  • Adalimumab Biosimilar = 0
  • Etrasimod = 0
  • Filgotinib = 0
  • Golimumab = 0
  • Infliximab - Remicade = 0
  • Infliximab Biosimilar = 3
  • Mirikizumab = 0
  • Ozanimod = 0
  • Risankizumab = 0
  • Tofacitinib = 2
  • Upadacitinib = 4
  • Ustekinumab = 1
  • Vedolizumab = 14

 

 

Protecting Your Online Privacy
Protecting Your Online Privacy

This Ashford and St Peter's website uses cookies to track visitor numbers. Find out more in our Cookies Policy and Privacy Policy. You can also read our Accessibility Statement and Privacy Notice for your information.